Implementation of an automated signal detection method in the French pharmacovigilance database: A feasibility study

European Journal of Clinical Pharmacology

Volumn 68, Issue 5, 2012, Pages 793-799

  Pizzoglio, Véronique ^a   Ahmed, Ismaïl ^b,c   Auriche, Pascal ^a   Tuber Bitter, Pascale ^b,c   Haramburu, Françoise ^d,e,f   Kreft Jaïs, Carmen ^g   Miremont Salamé, Ghada ^d,e,f  

^a AFSSAPS   (France)

^b CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d UNIVERSITÉ DE BORDEAUX   (France)

^e INSERM U657   (France)

^f BORDEAUX UNIVERSITY HOSPITAL   (France)

^g UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Feasibility study; Pharmacovigilance; Signal detection

Indexed keywords

ARTICLE; AUTOMATION; BAYES THEOREM; DATA BASE; DRUG SURVEILLANCE PROGRAM; FEASIBILITY STUDY; FOLLOW UP; FRANCE; PRIORITY JOURNAL; QUESTIONNAIRE; SIGNAL DETECTION;

ADVERSE DRUG REACTION REPORTING SYSTEMS; BAYES THEOREM; DATA MINING; DATABASES, FACTUAL; FEASIBILITY STUDIES; FRANCE; HEALTH PLAN IMPLEMENTATION; HUMANS; PHARMACOVIGILANCE; PILOT PROJECTS; PROSPECTIVE STUDIES; WORKLOAD;

EID: 84864288772     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-011-1178-1     Document Type: Article

References (33)

1. Bate A, Lindquist M, Edwards IR, Olsson S, Orre R, Lansner A et al (1998) Bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol 54(4):315-321 (Pubitemid 28328016)
2. Norén GN, Bate A, Orre R, Edwards IR (2006) Extending the methods used to screen the WHO drug safety database towards analysis of complex associations and improved accuracy for rare events. Stat Med 25(21):3740-3757 (Pubitemid 44613906)
3. DuMouchel W (1999) Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system. Am Stat 53(3):177-190
4. DuMouchel W, Pregibon D (2001) Empirical bayes screening for multi-item associations [Internet]. In: Proceedings of the Seventh ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. ACM, San Francisco, p 67-76. Available from: http://portal.acm.org/citation.cfm?id0502526. Accessed 26 March 2010
5. Szarfman A, Machado SG, O'Neill RT (2002) Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database. Drug Saf 25(6):381-392 (Pubitemid 34729136)
6. Van Puijenbroek EP, Bate A, Leufkens HGM, Lindquist M, Orre R, Egberts ACG (2002) A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf 11(1):3-10 (Pubitemid 34269590)
7. Evans SJ, Waller PC, Davis S (2001) Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf 10(6):483-486 (Pubitemid 34100774)
8. Hauben M, Madigan D, Gerrits CM, Walsh L, Van Puijenbroek EP (2005) The role of data mining in pharmacovigilance. Expert Opin Drug Saf 4(5):929-948 (Pubitemid 41246142)
9. Bate A, Evans SJW (2009) Quantitative signal detection using spontaneous ADR reporting. Pharmacoepidemiol Drug Saf 18 (6):427-436
10. Roux E, Thiessard F, Fourrier A, Bégaud B, Tubert-Bitter P (2005) Evaluation of statistical association measures for the automatic signal generation in pharmacovigilance. IEEE Trans Inf Technol Biomed 9(4):518-527 (Pubitemid 43009859)
11. Matsushita Y, Kuroda Y, Niwa S, Sonehara S, Hamada C, Yoshimura I (2007) Criteria revision and performance comparison of three methods of signal detection applied to the spontaneous reporting database of a pharmaceutical manufacturer. Drug Saf 30(8):715-726 (Pubitemid 47295831)
12. Ahmed I, Thiessard F, Miremont-Salamé G, Bégaud B, Tubert-Bitter P (2010) Pharmacovigilance data mining with methods based on false discovery rates: a comparative simulation study. Clin Pharmacol Ther 88(4):492-498
13. Hochberg AM, Hauben M, Pearson RK, O'Hara DJ, Reisinger SJ, Goldsmith DI et al (2009) An evaluation of three signal-detection algorithms using a highly inclusive reference event database. Drug Saf 32(6):509-525
14. Thiessard F (2004) Détection des effets indésirables des médicaments par un système de génération automatisée du signal adapté à la base nationale de pharmacovigilance [thesis]. Université Victor Ségalen Bordeaux 2
15. Lehman HP, Chen J, Gould AL, Kassekert R, Beninger PR, Carney R et al (2007) An evaluation of computer-aided disproportionality analysis for post-marketing signal detection. Clin Pharmacol Ther 82(2):173-180 (Pubitemid 47075337)
16. Hochberg AM, Hauben M, Pearson RK, O'Hara DJ, Reisinger SJ (2009) Systematic investigation of time windows for adverse event data mining for recently approved drugs. J Clin Pharmacol 49(6):626-633
17. Alvarez Y, Hidalgo A, Maignen F, Slattery J (2010) Validation of statistical signal detection procedures in eudravigilance post-authorization data: a retrospective evaluation of the potential for earlier signalling. Drug Saf 33(6):475-487
18. Ahmed I, Thiessard F, Miremont-Salamé G, Haramburu F, Kreft-Jais C, Bégaud B et al. Early detection of pharmacovigilance signals with automated methods based on false discovery rates: a comparative study. Drug Saf (in press)
19. Hochberg AM, Hauben M (2009) Time-to-signal comparison for drug safety data-mining algorithms vs. traditional signaling criteria. Clin Pharmacol Ther 85(6):600-606
20. Ahmed I, Haramburu F, Fourrier-Réglat A, Thiessard F, Kreft-Jais C, Miremont-Salamé G et al (2009) Bayesian pharmacovigilance signal detection methods revisited in a multiple comparison setting. Stat Med 28(13):1774-1792
21. Ahmed I, Dalmasso C, Haramburu F, Thiessard F, Broët P, Tubert-Bitter P (2010) False discovery rate estimation for frequentist pharmacovigilance signal detection methods. Biometrics 66(1):301-309
22. Almenoff JS, Pattishall EN, Gibbs TG, DuMouchel W, Evans SJW, Yuen N (2007) Novel statistical tools for monitoring the safety of marketed drugs. Clin Pharmacol Ther 82(2):157-166 (Pubitemid 47078877)
23. Thiessard F, Roux E, Miremont-Salamé G, Fourrier-Réglat A, Haramburu F, Tubert-Bitter P et al (2005) Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986-2001). Drug Saf 28(8):731-740 (Pubitemid 41132459)
24. R Development Core Team (2011) R: a language and environment for statistical computing [internet]. Vienna, Austria. Available from: http://www.R-project.org
25. Ahmed I, Poncet A (2010) PhViD: a R package for Pharmaco-Vigilance signal detection [internet]. Available from: http://cran.r-project.org/web/packages/ PhViD/index.html
26. Bégaud B, Evreux JC, Jouglard J, Lagier G (1985) Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France. Therapie 40(2):111-118
27. Moore N, Kreft-Jais C, Haramburu F, Noblet C, Andrejak M, Ollagnier M et al (1997) Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: a case/non-case study in the French pharmacovigilance system database. Br J Clin Pharmacol 44(5):513-518 (Pubitemid 27485484)
28. Tubert P, Bégaud B, Haramburu F, Péré JC (1991) Spontaneous reporting: how many cases are required to trigger a warning? Br J Clin Pharmacol 32(4):407-408
29. Tubert-Bitter P, Begaud B, Moride Y, Chaslerie A, Haramburu F (1996) Comparing the toxicity of two drugs in the framework of spontaneous reporting: a confidence interval approach. J Clin Epidemiol 49(1):121-3 (Pubitemid 26089559)
30. Fourrier A, Bégaud B, Alpérovitch A, Verdier-Taillefer MH, Touzé E, Decker N et al (2001) Hepatitis B vaccine and first episodes of central nervous system demyelinating disorders: a comparison between reported and expected number of cases. Br J Clin Pharmacol 51(5):489-490 (Pubitemid 32852989)
31. Brown EG, Wood L, Wood S (1999) The medical dictionary for regulatory activities (MedDRA). Drug Saf 20(2):109-117 (Pubitemid 29101275)
32. Miller GC, Britt H (1995) A new drug classification for computer systems: the ATC extension code. Int J Biomed Comput 40(2):121-124 (Pubitemid 26019935)
33. European Medicines Agency (2009) EudraVigilance-Human Status Report [internet]. Available from: http://www.ema.europa.eu/docs/en-GB/document- library/Report/2010/10/WC500097692.pdf. Accessed 17 June 2011